EN
HI
Concord Drugs Share price
CONCORD
81.8
1.45 (-1.74%)Last updated on 20 Feb, 2026 | 14:38 IST
BUYSELL
Today's High
86.59
Today's Low
81.60
52 Week Low
26.10
52 Week High
92.52
Free Demat with Zero AMC*
Concord Drugs Chart
Concord Drugs Share Key Metrics
Volume
1195.00
Market Cap
109.68 CR
LTQ@LTP
3@81.80
ATP
83.72
Var Margin
25.53 %
Circuit Range
79.09-87.41
Delivery %
0 %
Value
1.00 L
ASM/GSM
No
Market Lot
1
Summary
At 20 Feb, 2026 | 14:38, Concord Drugs share price stands at ₹81.8, showing a 1.45% -1.74 for the day. The stock’s intraday movement has stayed between ₹81.60 and ₹86.59, while on a 52-week basis it has fluctuated from ₹26.10 to ₹92.52.
In terms of trading activity, Concord Drugs has recorded a volume of 1195 shares, with a market capitalisation of ₹13175000. The stock’s Average Traded Price (ATP) stands at ₹8372, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3,8180. The stock operates within a circuit range of ₹79.09-87.41, with a Value of ₹1.00 L. The Delivery Percentage for the day is %. Additionally, Concord Drugs currently falls under the No framework, and trades with a market lot size of 1.
Concord Drugs Fundamentals
View MoreP/E Ratio
193.78
P/B Ratio
2.38
Div. Yield
0
Sector P/E
63.82
Sector P/B
2.76
Sec. Div. Yield
0.57
Concord Drugs Resistance and Support
Pivot 83.95
Resistance
First Resistance
86.29
Second Resistance
89.34
Third Resistance
91.68
Support
First Support
80.9
Second Support
78.56
Third Support
75.51
Concord Drugs Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-14 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-08 | Quarterly Results |
| 2025-07-03 | Preferential issue of shares |
| 2025-06-27 | Preferential Issue of shares & Others |
| 2025-05-23 | Audited Results |
| 2025-03-17 | Preferential Issue of shares & Others |
| 2025-03-13 | Preferential Issue of shares & Others |
| 2025-01-11 | Quarterly Results |
Concord Drugs News
BRIEF-Concord Drugs Says Approved Sale Of Non-Agricultural/Industrial Land, Ground, With Structures In Uttarakhand State
Oct 13 2020 19:21:03
Read More
About Concord Drugs
NSE : 0
BSE : 538965
ISIN : INE858L01010
CONCORD DRUGS LIMITED a company with its registered office at 5-9-22/36 Adarsha Nagar Hyderabad - 500463 (With effect from 14196 as for resolution dated 1.4.96 Change of Registered Office is being file with ROC was incorporated as a public limited company on 24th April 1995. The factory of the company is situated at survey No.s 248-251 Torruru Village Brahmanapally post Hyathnagar mandal R.R.Dist. Andhra Pradesh. The main objects of the company is to carry on the business of manufacturing and selling of pharmaceuticals formulations i.e. Tablets Capsules Liquids and Sterile Powder Injections Bio Adhesive and Radio Opec agent.SUBSIDIARIES OF THE COMPANYThe company has no subsidiary.
Concord Drugs Management
| Name | Position |
|---|---|
| Mr. S Nagi Reddy | Chairman & Managing Director |
| Mr. S Manoj Kumar Reddy | Whole Time Director |
Concord Drugs Similar Stocks
Raaj Medisafe India Ltd.
85.99
0.00 (0.00%)
Bal Pharma Ltd.
78.47
0.46 (0.59%)
Pharmaids Pharmaceuticals Ltd.
35.03
0.08 (0.23%)
Mercury Laboratories Ltd.
815.30
15.00 (1.87%)
Bharat Immunologicals & Biologicals Corporation Ltd.
18.22
-0.48 (2.57%)
Fortis Malar Hospitals Ltd.
54.51
-0.57 (1.03%)
Everest Organics Ltd.
369.00
0.65 (0.18%)
Godavari Drugs Ltd.
82.51
-2.87 (3.36%)
Concord Drugs FAQs
The Buying Price of Concord Drugs share is 81.8 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Concord Drugs stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Concord Drugs, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Concord Drugs shares is 193.78. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Concord Drugs shares is 2.38. Useful to assess the stock's value relative to its book value.
To assess Concord Drugs’s valuation compare Sector P/E, P/B which are 63.82 & 2.76 with sector averages, along with growth rates and financial metrics.
The Market Cap of Concord Drugs is 109.68 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Concord Drugs share price is 92.52 & 26.10. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Concord Drugs belongs to the Healthcare sector.
